Patents by Inventor Ramon Polo

Ramon Polo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and device to extend the life cycle of a wind turbine
    Patent number: 11933268
    Abstract: A nacelle includes in turn a nacelle frame, and a yaw bearing having likewise/in turn at least a geared ring for providing a rotatable connection between the nacelle and the tower around a yaw axis. A method includes the steps of: a) disengaging the rotatable connection between the nacelle and the tower; b) lifting the nacelle from the tower by using lifting means, allowing the rotation of the geared ring; and c) rotating the geared ring around the yaw axis until the geared ring reaches a predetermined position with respect to the component to which the geared ring is connectable, either to the nacelle or the tower.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: March 19, 2024
    Assignee: NORDEX ENERGY SPAIN S.A.U.
    Inventors: Miguel Nunez Polo, Teresa Arlaban Gabeiras, Jose Miguel Garcia Sayes, Francisco Fernandez Faraldo, Vicente Pigueiras Martinez, Jose Ramon Franco Caaveiro
  • Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis
    Patent number: 8871812
    Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: October 28, 2014
    Inventors: Robert S. Kauffman, Cyril Jean Camille Titeux, Ramon Polo, Rudolf Peter Gerhard Van Heeswijk, Maria Gloria Beumont, Gaston Rafael Picchio
  • THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS
    Publication number: 20130101554
    Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms.
    Type: Application
    Filed: December 18, 2012
    Publication date: April 25, 2013
    Applicant: Vertex Pharmaceutical Incorporated
    Inventors: ROBERT S. KAUFFMAN, Cyril Jean Camille Titeux, Ramon Polo, Rudolf Peter Gerhardt Van Heeswijk, Maria Gloria Beumont, Gaston Rafael Picchio
  • HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir
    Publication number: 20120039850
    Abstract: The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of patients with bridging fibrosis infected with HCV using the combination therapy.
    Type: Application
    Filed: August 11, 2011
    Publication date: February 16, 2012
    Applicants: Janssen Pharmaceutica NV, Vertex Pharmaceuticals Incorporated
    Inventors: Lindsay McNair, Robert S. Kauffman, John J. Alam, Ramon Polo, Gaston Rafael Picchio, Maria Gloria Beumont
  • Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis
    Publication number: 20110236351
    Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms.
    Type: Application
    Filed: March 24, 2011
    Publication date: September 29, 2011
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Robert S. Kauffman, Cyrill Jean Camille Titeux, Ramon Polo, Rudolf Peter Gerhardt Van Heeswijk, Maria Gloria Beumont, Gaston Rafael Picchio
  • TELAPREVIR DOSING REGIMEN
    Publication number: 20110165119
    Abstract: This invention relates to the use of specific dosing regimens of telaprevir in combination with peg-IFN and RBV in the treatment of HCV patients, wherein the treatment comprises (a) a lead-in phase of administering to the subject pegylated interferon and ribavirin, and (b) a treatment phase of administering to the subject a combination of telaprevir, pegylated interferon and ribavirin.
    Type: Application
    Filed: June 10, 2009
    Publication date: July 7, 2011
    Inventors: Maria Gloria Beumont, Stefan Rikard Herdinius, Gaston Rafael Picchio, Ramon Polo, Robert S. Kauffman, Bambang S. Adiwijaya, Varun Garg